Oxytocin (medication)
| Clinical data | |
|---|---|
| Pronunciation | /ˌɒksɪˈtoʊsɪn/ |
| Trade names | Pitocin, Syntocinon, Viatocinon, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682685 |
| License data | |
| Pregnancy category |
|
| Routes of administration | Intranasal, intravenous, intramuscular |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Liver and elsewhere (via oxytocinases) |
| Elimination half-life | 1–6 min (IV) ~2 h (intranasal) |
| Excretion | Bile duct and kidney |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C43H66N12O12S2 |
| Molar mass | 1007.19 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Synthetic oxytocin, sold under the brand name Pitocin among others, is a medication made from the peptide oxytocin. As a medication, it is used to cause contraction of the uterus to start labor, increase the speed of labor, and to stop bleeding following delivery. For this purpose, it is given by injection either into a muscle or into a vein.
Oxytocin is also available in intranasal spray form for psychiatric, endocrine and weight management use as a supplement. Intranasal oxytocin works on a different pathway than injected oxytocin, primarily along the olfactory nerve crossing the blood–brain barrier to the olfactory lobe in the brain, where dense magnocellular oxytocin neurons receive the nerve impulse quickly.
The natural occurrence of oxytocin was discovered in 1906. It is on the World Health Organization's List of Essential Medicines.